| 12448388 |
PRMT5 inhibitors and uses thereof |
Megan K. Armstrong, Elbert Chin, Charles C. Chou, Laurent P. Debien, Yifan Deng +10 more |
2025-10-21 |
|
| 12049439 |
Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives |
Julie Farand, Joshua A. Kaplan, Casey Lockwood Olen, Michael Sangi, David Sperandio |
2024-07-30 |
|
| 11999717 |
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof |
Brian P. Bestvater, Zhimin Du, Julie Farand, Barton W. Phillips, Doris T. Tang +4 more |
2024-06-04 |
$207,190,000 |
| 11548871 |
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof |
Brian P. Bestvater, Zhimin Du, Julie Farand, Barton W. Phillips, Doris T. Tang +4 more |
2023-01-10 |
$214,003,000 |
| 11136290 |
Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives |
Julie Farand, Joshua A. Kaplan, Casey Lockwood Olen, Michael Sangi, David Sperandio |
2021-10-05 |
|
| RE48711 |
Apoptosis signal-regulating kinase inhibitors |
Britton Kenneth Corkey, Michael Graupe, Keith Koch, Lawrence S. Melvin, Jr. |
2021-08-31 |
|
| 10946004 |
Solid forms of an ASK1 inhibitor |
Mark Andres, Brenda J. Burke Chan, Ernest A. Carra, Anna Chiu, Olga Viktorovna Lapina +3 more |
2021-03-16 |
$350,729,000 |
| RE48150 |
Apoptosis signal-regulating kinase inhibitors |
Britton Kenneth Corkey, Jeff Zablocki |
2020-08-11 |
|
| 10508100 |
Apoptosis signal-regulating kinase inhibitor |
— |
2019-12-17 |
$176,312,000 |
| 10307427 |
Apoptosis signal-regulating kinase inhibitors |
— |
2019-06-04 |
$121,883,000 |
| 10005774 |
Syk inhibitors |
Peter A. Blomgren, Jayaraman Chandrasekhar, Kevin S. Currie, Zhimin Du, Julie Farand +24 more |
2018-06-26 |
$460,376,000 |
| 9943521 |
Apoptosis signal-regulating kinase inhibitors |
— |
2018-04-17 |
$229,971,000 |
| 9907790 |
Solid forms of an ASK1 inhibitor |
— |
2018-03-06 |
$256,877,000 |
| 9908875 |
Apoptosis signal-regulating kinase inhibitors |
— |
2018-03-06 |
$256,877,000 |
| 9873682 |
Apoptosis signal-regulating kinase inhibitor |
— |
2018-01-23 |
$174,109,000 |
| 9750730 |
Apoptosis signal-regulating kinase inhibitor |
— |
2017-09-05 |
$281,619,000 |
| 9682998 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +9 more |
2017-06-20 |
$270,182,000 |
| 9643956 |
Solid forms of an ASK1 inhibitor |
Mark Andres, Brenda J. Burke Chan, Ernest A. Carra, Anna Chiu, Olga Viktorovna Lapina +3 more |
2017-05-09 |
$217,826,000 |
| 9586932 |
Apoptosis signal-regulating kinase inhibitors |
Michael Graupe, Keith Koch, Britton Kenneth Corkey, Lawrence S. Melvin, Jr. |
2017-03-07 |
$250,375,000 |
| 9586933 |
Processes for preparing ASK1 inhibitors |
— |
2017-03-07 |
$250,375,000 |
| 9403782 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +9 more |
2016-08-02 |
$640,089,000 |
| 9376441 |
Substituted pyrrolidines as SYK inhibitors |
Kevin S. Currie, Zhimin Du, Julie Farand, Juan A. Guerrero, Ashley Anne Katana +24 more |
2016-06-28 |
$306,177,000 |
| 9371329 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Tetsuya Kobayashi +5 more |
2016-06-21 |
$611,992,000 |
| 9333197 |
Apoptosis signal-regulating kinase inhibitor |
— |
2016-05-10 |
$594,394,000 |
| 9254284 |
Apoptosis signal-regulating kinase inhibitor |
— |
2016-02-09 |
$342,012,000 |